Trial
NCT01789047
Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Rush University Medical Center
Collaborators
Michael J. Fox Foundation for Parkinson's Research
Condition
Idiopathic Parkinson's Disease
Intervention
Topiramate
Why stopped
Sponsor withdrew support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-16